VR Logo

Oxygenta Pharmaceutical: Board Meeting Outcome for Submission Of Un-Audited Financial Results For The Quarter Ended 30Th June 2022
Ref: Regulation 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015


The Board at its meeting held today i.e. Friday 12th August 2022 transacted inter-alia the following businesses:

1. Financial Results:
The Board approved the Un-audited Financial Results for the first quarter ended 30th June 2022. In this regard please find the enclosed:

? Un-audited Financial Results of the Company for the quarter ended 30th June 2022

? Limited Review Report in respect of the Un-audited Financial Results of the Company for the first quarter ended 30th June 2022

2. Other Corporate matters

This is for your information and records.

Click here to view PDF